The global Microbial Identification market is segmented on the basis of product & service, method, application, end user and region. The market growth is primarily driven by the rising incidence of infectious diseases coupled with epidemic and pandemic outbreaks, increasing food safety concerns, technological advancements in microbial identification techniques, and government initiatives and funding to promote microbial identification.

By product and service, the global market is segmented into instruments, consumables, and services. The instruments segment is estimated to account for the largest market share of the global market in 2017. Factors driving the growth of this segment include the extensive use of instruments and advances in technology to develop innovative instruments.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10702182

By method, the market is classified into phenotypic methods, proteomics-based methods, and genotypic methods. The phenotypic methods segment is estimated to account for the largest share of the global microbial identification market. The large share of this segment can be attributed to features like cost-effectiveness, ease of use, and ability to deliver results rapidly which lead to their increased adoption across different end users.

On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, and blood banks; food manufacturing companies; beverage manufacturing companies; pharmaceutical companies and CROs; and other end users. The hospitals, diagnostic laboratories, and blood banks segment is estimated to account for the largest share of the global market. Rising prevalence of various infectious diseases coupled with periodic outbreaks of pandemics and epidemics are major factors driving the growth of this end user segment.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=10702182

Based on region, the microbial identification market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the microbial identification market in 2017. This is attributed to factors like increasing adoption of microbial identification techniques for research purposes; rising prevalence of infectious diseases; growing incidence of foodborne infections, safety concerns; and technological advancements in microbial identification products in the region as compared to other regions.

Key players in the microbial identification market include Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), bioMérieux S.A. (France), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Bruker Corporation (US), Shimadzu Corporation (Japan), VWR Corporation (US), Eurofins Scientific S.E. (Luxembourg), GTCR, LLC. (US), QIAGEN N.V. (Netherlands), Liofilchem s.r.l. (Italy), IEH Laboratories & Consulting Group (US), Alcami Corporation (US), Biolog, Inc. (US), Abellon CleanEnergy Limited (India), Alpha Analytical, Inc. (US), NeoGenomics, Inc. (US), Trivitron Healthcare (India), Molzym GmbH & Co. KG (Germany), Dynatec Labs (US), Altogen Labs (US), STERIS plc (UK), and Wickham Laboratories Ltd. (UK).

 Read More@
https://www.marketsandmarkets.com/PressReleases/microbial-identification.asp

The market growth is primarily driven by the rising incidence of infectious diseases coupled with epidemic and pandemic outbreaks, increasing food safety concerns, technological advancements in microbial identification techniques, and government initiatives and funding to promote microbial identification.

The microbial identification market is expected to reach USD 3.00 Billion by 2022 from USD 2.04 Billion in 2016 at a CAGR of 6.6%.

Market Dynamics 

+ Drivers

+ Rising Incidence of Infectious Diseases Coupled with Epidemic and Pandemic Events
+ Technological Advancements in Microbial Identification
+ Increasing Food Safety Concerns
+ Government Initiatives and Funding for Promoting Microbial Identification

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=10702182

The market is segmented into phenotypic, genotypic, and proteomics-based methods. The phenotypic methods segment is anticipated to account for the largest share of the global microbial identification market in 2017. These methods are cost-effective, easy to perform, and can deliver results rapidly. Therefore, they are widely adopted across industries, which is a major factor responsible for the large share of this segment.

The microbial identification market is categorized into hospitals, diagnostic laboratories, and blood banks; food manufacturing companies; beverage manufacturing companies; pharmaceutical companies and CROs; and other end users. The hospitals, diagnostic laboratories, and blood banks segment is estimated to account for the largest share of the global microbial identification market in 2017. The heavy burden of different infectious diseases, along with periodic outbreaks of pandemic and epidemic diseases are the key factors driving the growth of this end user segment.

View complete press release:-
https://www.marketsandmarkets.com/PressReleases/microbial-identification.asp